Subscribe To
Amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator
Amylyx pharmaceuticals Inc. AMLX, -4.60% shares fell 7.5% premarket on Friday after the company said th...
October 13, 2023, 8:31 am
Eu regulator declines to recommend amylyx' als drug
Amylyx pharmaceuticals said on Friday the European Union medicines regulator for the second time declin...
October 13, 2023, 8:28 am
The surprising $5 billion opportunity that drove vertex pharmaceuticals stock to a record high
Almost three-quarters of prescribed pain meds are opioids, and Vertex could change that. VRTX stock broke out to a record high Thursday....
October 12, 2023, 3:17 pm
Olema oncology kat6 inhibitor compounds demonstrate potent anti-tumor activity
Preclinical data to be presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics SAN FRANCISCO, Oct. ...
October 12, 2023, 11:01 am
Tonix pharmaceuticals to present at the 2023 thinkequity conference
CHATHAM, N.J., Oct. 12, 2023 (GLOBE NEWSWIRE) — Tonix pharmaceuticals Holding Corp. (Nasdaq: TNXP), a...
October 12, 2023, 11:00 am
Conduit pharmaceuticals partners with clinconnect on cocrystal development program for azd1656
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed Phase I trials SAN DIEG...
October 11, 2023, 12:30 pm
Pmv pharmaceuticals to present updated phase 1 data on pc14586 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics and host a kol webinar
PRINCETON, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery an...
October 11, 2023, 12:00 pm
Phio pharmaceuticals presents new data for targeting of brd4 with its intasyl™ compound ph-894
–Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination –Pre...
October 11, 2023, 11:30 am
Here's why momentum in olema pharmaceuticals, inc. (olma) should keep going
Olema Pharmaceuticals, Inc. (OLMA) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a prof...
October 11, 2023, 10:32 am
Is recursion pharmaceuticals stock a buy now?
Recursion pharmaceuticals is using a novel and promising approach to drug discovery. Its strategy has p...
October 11, 2023, 10:07 am
Amphastar pharmaceuticals: great growth at a high price
Amphastar pharmaceuticals has implemented aggressive corporate strategies to maximize margins and incre...
October 10, 2023, 9:41 pm
Alnylam: fda rejection of onpattro for attr-cm is a setback, but a manageable one
Despite a positive panel recommendation, the FDA rejected the Alnylam Pharmaceuticals, Inc. application to market Onpattro for ATTR-CM, citing a lack ...
October 10, 2023, 6:08 pm
Lgnd vs. ilmn: which stock should value investors buy now?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Ligand ...
October 10, 2023, 12:47 pm
Jazz or zts: which is the better value stock right now?
Investors looking for stocks in the Medical - Drugs sector might want to consider either Jazz pharmaceuticals ...
October 10, 2023, 12:47 pm
Why shares of lexicon pharmaceuticals are up tuesday
Lexicon just launched heart failure therapy Inpefa this year. The drug was approved by the FDA in May....
October 10, 2023, 11:25 am
Are medical stocks lagging amphastar pharmaceuticals (amph) this year?
Here is how Amphastar pharmaceuticals (AMPH) and Acadia pharmac...
October 10, 2023, 11:17 am
Lexicon pharmaceuticals shares rise on express scripts support for inpefa heart drug
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares jumped 9% in Tuesday pre-market trading after it announced that its Inpefa heart failure drug has ...
October 10, 2023, 7:47 am
Should you invest in the ishares u.s. pharmaceuticals etf (ihe)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. p...
October 10, 2023, 7:31 am
Vertex pharmaceuticals (vrtx) stock falls amid market uptick: what investors need to know
In the most recent trading session, Vertex pharmaceuticals (VRTX) closed at $355.20, indicating a -1.5%...
October 9, 2023, 7:33 pm
Amphastar pharmaceuticals (amph) rises higher than market: key facts
In the closing of the recent trading day, Amphastar pharmaceuticals (AMPH) stood at $47.55, denoting a ...
October 9, 2023, 7:32 pm